CASP3 and osteosarcoma: HACE1 overexpression inhibited primary tumor growth of osteosarcoma xenografts in vivo, with significantly increased rates of necrosis and caspase-3 activation compared to tumors expressing vector alone or HACE1-C876S in vivo.